Serine dipeptidase DPP8/9 inhibitors, which activate GSDMD-mediated pyroptosis in human myeloid cells, induce pyroptosis in most human acute myeloid leukemia cell lines and primary cells but not cells from other lineages, presenting a novel therapeutic strategy for acute myeloid leukemia (93). This evidence concerns the gene GSDMD and acute myeloid leukemia.